Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, India, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands. It also provides analgesics; sore throat medications; and hair removal products under the Nurofen, Strepsils, and Veet brands. In addition, the company offers fragrances and devices; water softeners; home cleaning products; dish washes; toilet cleaners; disinfectants; sprays, baits, and plug-ins for pest control; stain removals; fabric washing; and other hygiene products under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands, as well as analgesics, adult nutrition products, iron-fortified hypoallergenic baby formula, products for joint issues, and infant and toddler nutrition products, as well as vitamins, minerals, and supplements under the Biofreeze, Airborne, Mead Johnson, Move Free, Enfamil, and Nutramigen brands. Further, it provides probiotics, sore throat pain relief products, Omega products, brain health support products, cleaning and carpet cleaning products, septic tank system treatment products, cough syrups, plant-based laundry products, probiotics, and lubricants under the Digestive Advantage, Cepacol, MegaRed, Neuriva, Easy-Off, RID-X, Delsym, Botanical Origin, Bodi-Ome, and K-Y brands. The company was founded in 1819 and is headquartered in Slough, the United Kingdom.

Reckitt Benckiser Group plc

Derivative Acquisition Under Employee Benefit Plan

Insider	Title	Transaction Type	Shares Traded	% of Shares Traded	% Chg. in Shares	End of Filing Shares	Price	Transaction Value	Filing Date	Transaction Date
Kristoffer Loe Licht	CEO & Executive Director Show All	Acquisition Under Employee Benefit Plan (Acquisition Under Employee Benefit Plan)	845.0	0.000124%	1.5%	58.6K	77.4 - 77.4	65.4K	22 Sep 2025	18 Sep 2025 - 18 Sep 2025
Shannon Sue Eisenhardt	CFO & Executive Director Show All	Acquisition Under Employee Benefit Plan (Acquisition Under Employee Benefit Plan)	76.0	0.000011%	1.5%	5.2K	77.4 - 77.4	5.9K	22 Sep 2025	18 Sep 2025 - 18 Sep 2025
Shannon Sue Eisenhardt	CFO & Executive Director Show All	Derivative Exercise and Retained Stock (Derivative Exercise and Retained Stock)	2.0K	0.000297%	64.2%	5.2K	—	—	01 Aug 2025	01 Aug 2025 - 01 Aug 2025
Shannon Sue Eisenhardt	CFO & Executive Director Show All	Derivative Exercise and Sale (Derivative Exercise and Sale)	-1.8K	-0.000264%	—	5.2K	74.9 - 74.9	-134.7K	01 Aug 2025	01 Aug 2025 - 01 Aug 2025
Tamara Ingram	Independent Non-Executive Director Show All	Open Market Acquisition (Open Market Acquisition)	293.0	0.000043%	51.9%	858.0	74.7 - 74.7	21.9K	31 Jul 2025	30 Jul 2025 - 30 Jul 2025
Marybeth Hays
D. Jeremy Darroch
Margherita Della Valle
Fiona Eleanor Dawson
Elane B. Stock
Andrew R. J. Bonfield
Kristoffer Loe Licht
Shannon Sue Eisenhardt
Kristoffer Loe Licht
Kristoffer Loe Licht
Susan Sholtis
Kristoffer Loe Licht
Shannon Sue Eisenhardt
Kristoffer Loe Licht
Kristoffer Loe Licht
Kristoffer Loe Licht
Susan Sholtis
Shannon Sue Eisenhardt
Shannon Sue Eisenhardt
Shannon Sue Eisenhardt
Shannon Sue Eisenhardt
Kristoffer Loe Licht
Andrew R. J. Bonfield
Elane B. Stock
Margherita Della Valle